Effects of Intravenous Administered Iron in Non-anemic Iron Deficient Patients With Colorectal Cancer

NCT05220800 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

134

Enrollment

OTHER

Sponsor class

Conditions

Iron-deficiency
Colorectal Cancer

Interventions

DRUG: Iron(III)isomaltoside
DRUG: Placebo

Sponsor

Zealand University Hospital

Collaborators

[object Object]
[object Object]